|
MX3676E
(es)
*
|
1975-07-15 |
1981-04-23 |
Abbott Lab |
Procedimiento para obtener derivados del antibiotico xk-62-2
|
|
MA21697A1
(fr)
*
|
1988-12-19 |
1990-07-01 |
Dow Agrosciences Llc |
Composes de macrolides.
|
|
DE4200145A1
(de)
*
|
1992-01-07 |
1993-07-08 |
Kali Chemie Pharma Gmbh |
7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US5591606A
(en)
*
|
1992-11-06 |
1997-01-07 |
Dowelanco |
Process for the production of A83543 compounds with Saccharopolyspora spinosa
|
|
ES2099604T3
(es)
*
|
1993-03-12 |
1997-05-16 |
Dowelanco |
Nuevos compuestos a83543 y procedimiento para su produccion.
|
|
US6001981A
(en)
*
|
1996-06-13 |
1999-12-14 |
Dow Agrosciences Llc |
Synthetic modification of Spinosyn compounds
|
|
DE19644195A1
(de)
*
|
1996-10-24 |
1998-04-30 |
Solvay Pharm Gmbh |
10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US5922849A
(en)
*
|
1996-11-22 |
1999-07-13 |
Abbott Laboratories |
Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
|
|
US5883236A
(en)
*
|
1997-11-19 |
1999-03-16 |
Abbott Laboratories |
Process for N-desmethylating erythromycins and derivatives thereof
|
|
US6084079A
(en)
*
|
1998-05-15 |
2000-07-04 |
Keyes; Robert F. |
Process for preparing N-demethyl-N-alkyl erythromycin derivatives
|
|
JP4573925B2
(ja)
*
|
1998-07-09 |
2010-11-04 |
アベンティス・ファーマ・ソシエテ・アノニム |
新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
|
|
US7348309B2
(en)
*
|
2001-03-30 |
2008-03-25 |
Wisconsin Alumni Research Foundation |
Glycorandomization and production of novel vancomycin analogs
|
|
ITMI20021726A1
(it)
*
|
2002-08-01 |
2004-02-02 |
Zambon Spa |
Macrolidi ad attivita' antiinfiammatoria.
|
|
WO2004092736A2
(en)
*
|
2003-04-17 |
2004-10-28 |
Sandoz Ag |
Derivatives of azithromycin
|
|
CA2530581A1
(en)
*
|
2003-06-23 |
2005-01-06 |
Auspex Pharmaceuticals |
Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
|
|
US8278281B2
(en)
|
2005-08-24 |
2012-10-02 |
Rib-X Pharmaceuticals, Inc. |
Triazole compounds and methods of making and using the same
|
|
CA2632779A1
(en)
*
|
2005-12-08 |
2007-06-14 |
Pfizer Inc. |
Method for demethylating the 3'-dimethylamino group of erythromycin compounds
|
|
JP2009539866A
(ja)
*
|
2006-06-05 |
2009-11-19 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換エリスロマイシンアナログの調製および有用性
|
|
SI2102226T1
(sl)
*
|
2006-12-12 |
2012-12-31 |
Zambon S.P.A. |
Makrolidne spojine s protivnetno aktivnostjo
|
|
WO2009006403A2
(en)
*
|
2007-06-29 |
2009-01-08 |
Georgia Tech Research Corporation |
Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
|
|
US8871728B2
(en)
|
2007-06-29 |
2014-10-28 |
Georgia Tech Research Corporation |
Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
|
|
JP2012516305A
(ja)
|
2009-01-30 |
2012-07-19 |
グラクソ グループ リミテッド |
好中球優位の炎症性疾患の治療のための９−デオキソ−９ａ−メチル−９ａ−アザ−９ａ−ホモエリスロマイシンａ誘導体
|
|
BRPI1006114A2
(pt)
|
2009-01-30 |
2018-02-06 |
Glaxo Group Ltd |
"macrolídeo antiinflamatório".
|
|
WO2011131749A1
(en)
|
2010-04-23 |
2011-10-27 |
Glaxo Group Limited |
New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
|
|
GB201520419D0
(en)
|
2015-11-19 |
2016-01-06 |
Epi Endo Pharmaceuticals Ehf |
Compounds
|
|
GB201608236D0
(en)
|
2016-05-11 |
2016-06-22 |
Fidelta D O O |
Seco macrolide compounds
|
|
CN108727445B
(zh)
*
|
2018-06-29 |
2021-06-11 |
宜昌东阳光生化制药有限公司 |
一种阿奇霉素杂质f的合成方法
|
|
WO2024194494A1
(en)
|
2023-03-22 |
2024-09-26 |
Epiendo Pharmaceuticals Ehf |
Azithromycin derivatives for use in the treatment of eosinophil-related diseases
|